Biotron Limited
Antiviral Therapeutics. Biotron’s lead compound, BIT225, is in Phase 2 development for the treatment of HIV-1 and Hepatitis C virus infections.
- 56, Delhi Rd, North Ryde, 2113, 2113, Sydney, New South Wales
- http://www.biotron.com.au
Biotron Limited
Business Organisation